Momentum building around tau: expect VY7523 clinical data and VY1706 clinical entry in 2026 - - Sharpened focus on ...
CAMBRIDGE, United Kingdom and LEXINGTON, Mass., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Transition Bio, a drug discovery company ...
Voyager is paying travel partner Transition Bio a single-digit million-dollar upfront payment, with additional payments up to ...
As investment platforms face near-constant technological change, advisers and clients alike demand progress that is both ...
Video. From its historic streets to its beautiful surroundings, Valencia is full of life and flavour. But what is it about ...
Fintel reports that on November 12, 2025, HC Wainwright & Co. maintained coverage of Voyager Therapeutics (NasdaqGS:VYGR) ...
Pinpointing Canadian content is tricky as vehicles assembled here are made up of about 30 to 40 per cent Canadian parts and ...
TipRanks on MSN
Voyager Technologies Issues $435M Convertible Notes
Voyager Technologies, Inc. Class A ( ($VOYG) ) has issued an announcement. On November 12, 2025, Voyager Technologies, Inc. issued $435 million in ...
According to TipRanks.com, Trucchio is a top 100 analyst with an average return of 34.8% and a 52.3% success rate. Trucchio covers the Healthcare sector, focusing on stocks such as Harmony Biosciences ...
Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of +11.32% and +57.01%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the ...
In this episode, Ray kicks things off with NASA’s Voyager mission uncovering extreme plasma temperatures—up to 50,000 ...
Transition Bio & Voyager collaborate to advance small molecules targeting TDP-43 in ALS and frontotemporal dementia: Cambridge, UK Wednesday, November 12, 2025, 13:00 Hrs [IST] Tr ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback